Article Information
History
- March 3, 2018.
Article Versions
- You are currently viewing Version 1 of this article (March 3, 2018 - 08:58).
- Version 2 (April 16, 2018 - 14:51).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hanna Najgebauer1,2,
- Mi Yang3,
- Hayley Francies4,
- Euan A Stronach1,5,
- Mathew J Garnett1,4,
- Julio Saez-Rodriguez1,2,3 and
- Francesco Iorio1,2,4,*
- 1Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK
- 2European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK
- 3Faculty of Medicine, JointResearch Centre for Computational Biomedicine, RWTH Aachen University, Aachen 52057, Germany
- 4Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK
- 5Target Sciences, GlaxoSmithKline, Stevenage, UK
- ↵*Correspondence: fi1{at}sanger.ac.uk